CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- 4 Open-market sale Director sold 664 shares at $61.13 ($40,590)
- 4 Planned sale Chief Financial Officer sold 2,031 shares at $59.00 ($119,829)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Financial Officer sold 2,000 shares at $57.50 ($115,000)
- 4 Planned sale Chief Executive Officer sold 34,800 shares at an average $55.33 ($1,925,525)
- 4 Planned sale Chief Executive Officer sold 5,200 shares at $55.09 ($286,454)
- 4 Exercise or conversion Chief Medical Officer acquired 32,070 shares (option exercise)
- 4 Planned sale Chief Financial Officer sold 2,000 shares at $52.26 ($104,519)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Medical Officer sold 2,996 shares at $50.00 ($149,800)
- 4 Planned sale Chief Medical Officer sold 6,677 shares at $50.04 ($334,128)
- 4 Planned sale Chief Medical Officer sold 2,100 shares at $50.17 ($105,367)
- 4 Exercise or conversion Chief Executive Officer acquired 7,000 shares (option exercise)
Page 4 of 15 · 283 filings